Formation of dysfunctional high-density lipoprotein by myeloperoxidase

Area of Science:

• Cardiovascular Biology
• Oxidative Stress Research
• Lipid Metabolism

Background:

• Dysfunctional high-density lipoprotein (HDL) particles are present in cardiovascular disease, exhibiting proinflammatory effects instead of atheroprotection.
• The mechanisms generating dysfunctional HDL remain largely unknown.

Purpose of the Study:

• To investigate the role of myeloperoxidase (MPO) in the generation of dysfunctional HDL within human atherosclerotic plaque.
• To elucidate the molecular interactions between MPO and HDL components.

Main Methods:

• Biophysical studies to analyze MPO binding to HDL.
• Investigation of MPO's interaction with apolipoprotein (apo) A-I.
• Assessment of HDL's cellular cholesterol efflux capacity following MPO interaction.

Main Results:

• Myeloperoxidase (MPO) binds to HDL within human atherosclerotic lesions.
• MPO specifically interacts with apolipoprotein A-I (apoA-I) on HDL.
• MPO-catalyzed apoA-I oxidation impairs HDL's ability to promote cholesterol efflux via the ATP-binding cassette-1 system.

Conclusions:

• MPO-generated oxidants contribute to HDL dysfunction in atherosclerosis.
• MPO-mediated alteration of apoA-I leads to loss of HDL's atheroprotective properties.
• This highlights a novel mechanism linking inflammation and oxidative stress to cardiovascular disease pathogenesis.